Insider Trading History of Harris Robert Paul

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Harris Robert Paul since 2013. The trader's CIK number is 1537250. At the time of the last reporting, Harris Robert Paul was the Chief Executive Officer of Aralez Pharmaceuticals Inc.. (stock ticker symbol ARLZ). Also see all insider trading activities at Aralez Pharmaceuticals Inc..

Note that in the past Harris Robert Paul also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Stellar Pharmaceuticals Inc (TBUFF) by Harris Robert Paul

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 TBUFF 1,725,000 $866,000 0 $0 0 $0

Yearly summary of insider trading at Aralez Pharmaceuticals Inc. (ARLZ) by Harris Robert Paul

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 ARLZ 0 $0 274,778 $1,489,306 124,778 $489,129


Insider trading activities at 2 companies by Harris Robert Paul:

1. Stellar Pharmaceuticals Inc (TBUFF)

2. Aralez Pharmaceuticals Inc. (ARLZ)

Table 1. Insider trading of Stellar Pharmaceuticals Inc (TBUFF) by Harris Robert Paul

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-02-27 TBUFF Buy 625,000 .40 250,000
2012-03-22 TBUFF Buy 1,100,000 .56 616,000

Table 2. Insider trading of Aralez Pharmaceuticals Inc. (ARLZ) by Harris Robert Paul

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-11-29 ARLZ Option Ex 104,778 3.92 410,729
2016-11-28 ARLZ Option Ex 20,000 3.92 78,400
2016-11-29 ARLZ Sale 104,778 4.99 523,156
2016-11-28 ARLZ Sale 20,000 4.65 93,000
2016-09-15 ARLZ Sale 150,000 5.82 873,150

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Harris Robert Paul (Chief Executive Officer of Aralez Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.